SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Leonardi S, Armstrong PW, Schulte PJ, et al. Implementation of standardized assessment and reporting of myocardial infarction in contemporary randomized controlled trials: A systematic review. Eur Heart J 2013;34:894902.
  • 2
    Thygesen K, Alpert JS, White HD, et al. Universal definition of myocardial infarction. Circulation 2007;116:26342653.
  • 3
    Thygesen K, Alpert JS, Allan S, et al. Third universal definition of myocardial infarction. Circulation 2012;60:15811598.
  • 4
    Lim CC, Cuculi F, van Gaal WJ, et al. Early diagnosis of perioperative myocardial infarction after coronary bypass grafting: A study using biomarkers and cardiac magnetic resonance imaging. Ann Thorac Surg 2011;92:20462053.
  • 5
    Muschart X, Slimani A, Jamart J, et al. The different mechanisms of periprocedural myocardial infarction and their impact on in-hospital outcome. J Invasive Cardiol 2012;24:655660.
  • 6
    Lee T, Yonetsu T, Koura K, et al. Impact of coronary plaque morphology assessed by optical coherence tomography on cardiac troponin elevation in patients with elective stent implantation. Circ Cardiovasc Interv 2011;4:378386.
  • 7
    Mehran R, Dangas G, Mintz GS, et al. Atherosclerotic plaque burden and CK-MB enzyme elevation after coronary intervention: Intravascular ultrasound study of 2256 patients. Circulation 2000;101:604610.
  • 8
    Kanaparti PK, Brown DL. Relation between coronary atherosclerotic plaque burden and cardiac enzyme elevation following percutaneous coronary intervention. Am J Cardiol 2000;86:619622.
  • 9
    van Gaal WJ, Ponnuthurai FA, Selvanayagam J, et al. The syntax score predicts peri-procedural myocardial necrosis during percutaneous coronary intervention. Int J Cardiol 2009;135:6065.
  • 10
    Garg S, Sarno G, Girasis C, et al. A patient-level pooled analysis assessing the impact of the SYNTAX (synergy between percutaneous coronary intervention with taxus and cardiac surgery) score on 1-year clinical outcomes in 6,508 patients enrolled in contemporary coronary stent trials. JACC Cardiovasc Interv 2011;4:645653.
  • 11
    Palmerini T, Genereux P, Caixeta A, et al. Prognostic value of the SYNTAX score in patients with acute coronary syndromes undergoing percutaneous coronary intervention: Analysis from the ACUITY (acute catheterization and urgent intervention triage strategy) trial. J Am Coll Cardiol 2011;57:23892397.
  • 12
    Cutlip DE, Kuntz RE. Cardiac enzyme elevation after successful percutaneous coronary intervention is not an independent predictor of adverse outcomes. Circulation 2005;112:916923.
  • 13
    Blankenship JC, Islam MA, Wood CG, Iliadis EA. Angiographic adverse events during percutaneous coronary intervention fail to predict creatine kinase-MB elevation. Cath Cardiovasc Int 2004;63:3141.
  • 14
    Jeremias A, Baim DS, Ho KK, et al. Differential mortality risk of postprocedural creatine kinase-MB elevation following successful versus unsuccessful stent procedures. J Am Coll Cardiol 2004;44:12101214.
  • 15
    Lansky AJ, Stone GW. Periprocedural myocardial infarction. Prevalence, prognosis, and prevention. Circ Cardiovasc Interv 2010;3:602610.
  • 16
    Panteghini M. A critical appraisal of experimental factors influencing the definition of the 99th percentile limit for cardiac troponins. Clin Chem Lab Med 2009;47:11791182.
  • 17
    Prasad A, Rihal CS, Lennon RJ, et al. Significance of periprocedural myonecrosis on outcomes after percutaneous coronary intervention: An analysis of preintervention and postintervention troponin T levels in 5487 patients. Circ Cardiovasc Interv 2008;1:1019.
  • 18
    Jeremias A, Kleiman NS, Nassif D, et al. Evaluation of drug eluting stents and ischemic events (EVENT) registry investigators. Prevalence and prognostic significance of preprocedural cardiac troponin elevation among patients with stable coronary artery disease undergoing percutaneous coronary intervention: Results from the evaluation of drug eluting stents and ischemic events registry. Circulation 2008;118:632638.
  • 19
    Bonaca MP, Wiviott SD, Braunwald E, et al. Universal definition of myocardial infarction classification system and the risk of cardiovascular death: Observations from the TRITON-TIMI 38 trial (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38). Circulation 2012;125:577583.
  • 20
    Jaffe AS, Ravkilde J, Roberts R, et al. It's time for a change to a troponin standard. Circulation 2000;102:12161220.
  • 21
    Adams JE III, Bodor GS, Davila-Roman VG, et al. Cardiac troponin I. A marker with high specificity for cardiac injury. Circulation 1993;88:101106.
  • 22
    Novack V, Pencina M, Cohen DJ, et al. Troponin criteria for myocardial infarction after percutaneous coronary intervention. Arch Intern Med 2012;172:502508.
  • 23
    Hamm CW, Giannitsis E, Katus HA. Cardiac troponin elevations in patients without acute coronary syndrome. Circulation 2002;106:666671.
  • 24
    Stone GW, Mehran R, Dangas G, et al. Differential impact on survival of electrocardiographic Q-wave versus enzymatic myocardial infarction after percutaneous intervention: A device-specific analysis of 7147 patients. Circulation 2001;104:642647.
  • 25
    Brener SJ, Ellis SG, Schneider J, Topol EJ. Frequency and long-term impact of myonecrosis after coronary stenting. Eur Heart J 2002;23:869876.
  • 26
    Lindsey JB, Kennedy KF, Stolker JM, et al. Prognostic implications of creatine kinase-MB elevation after percutaneous coronary intervention: Results from the evaluation of drug-eluting stents and ischemic events (EVENT) registry. Circ Cardiovasc Interv 2011;4:474480.
  • 27
    Stone GW, Rizvi A, Newman W, et al. SPIRIT IV investigators. Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease. N Engl J Med 2010;362:16631674.
  • 28
    Damman P, Wallentin L, Fox KA, et al. Long-term cardiovascular mortality after procedure-related or spontaneous myocardial infarction in patients with non-ST-segment elevation acute coronary syndrome: A collaborative analysis of individual patient data from the FRISC II, ICTUS, and RITA-3 trials (FIR). Circulation 2012;125:568576.
  • 29
    Ricciardi MJ, Wu E, Davidson CJ, et al. Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation. Circulation 2001;103:27802783.
  • 30
    Rioufol G, Finet G, Ginon I, et al. Multiple atherosclerotic plaque rupture in acute coronary syndrome: A three-vessel intravascular ultrasound study. Circulation 2002;106:804808.
  • 31
    Tanaka A, Shimada K, Sano T, et al. Multiple plaque rupture and C-reactive protein in acute myocardial infarction. J Am Coll Cardiol 2005;45:15941599.
  • 32
    Zhao Z, Witzenbichler B, Mintz GS, et al. Dynamic nature of nonculprit coronary artery lesion morphology in STEMI. J Am Coll Cardiol Img 2013;6:8695.
  • 33
    Klem I, Shah DJ, White RD, et al. Prognostic value of routine cardiac magnetic resonance assessment of left ventricular ejection fraction and myocardial damage: An international, multicenter study. Circ Cardiovasc Imaging 2011;4:610619.
  • 34
    Porto I, Selvanayagam JB, Van Gaal WJ, et al. Plaque volume and occurrence and location of periprocedural myocardial necrosis after percutaneous coronary intervention: Insights from delayed-enhancement magnetic resonance imaging, thrombolysis in myocardial infarction myocardial perfusion grade analysis, and intravascular ultrasound. Circulation 2006;114:662669.
  • 35
    Lim CC, van Gaal WJ, Testa L, et al. With the “universal definition,” measurement of creatine kinase-myocardial band rather than troponin allows more accurate diagnosis of periprocedural necrosis and infarction after coronary intervention. J Am Coll Cardiol 2011;57:653661.
  • 36
    Eigel P, van Ingen G, Wagenpfeil S. Predictive value of perioperative cardiac troponin I for adverse outcome in coronary artery bypass surgery. Eur J Cardiothorac Surg 2001;20:544549.
  • 37
    Selvanayagam JB, Petersen SE, Francis JM, et al. Effects of off-pump versus on-pump coronary surgery on reversible and irreversible myocardial injury: A randomized trial using cardiovascular magnetic resonance imaging and biochemical markers. Circulation 2004;109:345350.
  • 38
    Mahaffey KW, Roe MT, Kilaru R, et al. Creatine kinase-MB elevation after coronary artery bypass grafting surgery in patients with non-ST-segment elevation acute coronary syndromes predict worse outcomes: Results from four large clinical trials. Eur Heart J 2007;28;425432.
  • 39
    Nesher N, Alghamdi AA, Singh SK, et al. Troponin after cardiac surgery: A predictor or a phenomenon? Ann Thorac Surg 2008;85:13481354.
  • 40
    Paparella D, Cappabianca G, Visicchio G, et al. Cardiac troponin I release after coronary artery bypass grafting operation: Effects on operative and midterm survival. Ann Thorac Surg 2005;80:17581764.
  • 41
    Ramsay J, Shernan S, Fitch J, et al. Increased creatine kinase MB level predicts postoperative mortality after cardiac surgery independent of new Q waves. J Thorac Cardiovasc Surg 2005;129:300306.
  • 42
    Klatte K, Chaitman BR, Theroux P, et al. Increased mortality after coronary artery bypass graft surgery is associated with increased levels of postoperative creatine kinase-myocardial band isoenzyme release: Results from the GUARDIAN trial. J Am Coll Cardiol 2001;38:10701077.
  • 43
    Costa MA, Carere RG, Lichtenstein SV, et al. Incidence, predictors, and significance of abnormal cardiac enzyme rise in patients treated with bypass surgery in the arterial revascularization therapies study (ARTS). Circulation 2001;104:26892693.
  • 44
    Croal BL, Hillis GS, Gibson PH, et al. Relationship between postoperative cardiac troponin I levels and outcome of cardiac surgery. Circulation 2006;114:14681475.
  • 45
    Vikenes K, Andersen KS, Melberg T, et al. Long time prognostic value of CK-MB mass in low-risk patients with stable angina scheduled for cardiac surgery. Cardiology 2009;113:122131.
  • 46
    Lurati Buse GA, Koller MT, Grapow M, et al. The prognostic value of troponin release after adult cardiac surgery—A meta-analysis. Eur J Cardiothorac Surg 2010;37:399406.
  • 47
    van Geene Y, van Swieten HA, Noyez L. Cardiac troponin I levels after cardiac surgery as predictor for in-hospital mortality. J Thorac Cardiovasc Surg 2009;10:413416.
  • 48
    Petaja L, Salmenpera M, Pulkki K, et al. Biochemical injury markers and mortality after coronary artery bypass grafting: A systematic review. Ann Thorac Surg 2009;87:19811992.
  • 49
    Domanski MJ, Mahaffey K, Hasselblad V, et al. Association of myocardial enzyme elevation and survival following coronary artery bypass graft surgery. JAMA 2011;305:585591.
  • 50
    Van Gall WJ, Arnold JR, Testa L, et al. Myocardial injury following coronary artery surgery versus angioplasty (MICASA): A randomized trial using biochemical markers and cardiac magnetic resonance imaging. EuroIntervention 2011;6:703710.
  • 51
    Steuer J, Berner T, Duvernoy O, et al. Visualization and quantification of perioperative myocardial infarction after coronary artery bypass surgery with contrast-enhanced magnetic resonance imaging. Eur Heart J 2004;25:12931299.
  • 52
    Rahimi K, Banning AP, Cheng ASH, et al. Prognostic value of coronary revascularization-related myocardial injury: A cardiac magnetic resonance imaging study. Heart 2009;95:19371943.
  • 53
    Remppis A, Scheffold T, Greten J, et al. Intracellular compartmentation of troponin T: Release kinetics after global ischemia and calcium paradox in the isolated perfused rat heart. J Mol Cell Cardiol 1995;27:793803.
  • 54
    Fitzmaurice TF, Brown C, Rifai N, et al. False increase of cardiac troponin I with heterophilic antibodies. Clin Chem 1998;44:22122214.
  • 55
    Krahn J, Parry DM, Leroux M, et al. High percentage of false positive cardiac troponin I results in patients with rheumatoid factor. Clin Biochem 1999;32:477480.
  • 56
    Bodor GS, Survant L, Voss EM, et al. Cardiac troponin T composition in normal and regenerating human skeletal muscle. Clin Chem 1997;43:476484.
  • 57
    Wang TY, Peterson ED, Dai D, et al. Patterns of cardiac marker surveillance after elective percutaneous coronary intervention and implications for the use of periprocedural myocardial infarction as a quality metric. J Am Coll Cardiol 2008;51:20682074.
  • 58
    Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol 2011;58:e44e122.
  • 59
    Morrow DA. Clinical application of sensitive troponin assays. N Engl J Med 2009;361:913915.
  • 60
    Venge P, Johnston N, Lindahl B, et al. Normal plasma levels of cardiac troponin I measured by the high-sensitivity cardiac troponin I access prototype assay and the impact on the diagnosis of myocardial ischemia. J Am Coll Cardiol 2009;54:11651172.
  • 61
    Omland T, de Lemos JA, Sabatine MS, et al. A sensitive cardiac troponin T assay in stable coronary artery disease. N Engl J Med 2009;361:25382547.
  • 62
    de Lemos JA, Drazner MH, Omland T, et al. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA 2010;304:25032512.
  • 63
    Roe MT, Messenger JC, Weintraub WS, et al. Treatments, trends, and outcomes of acute myocardial infarction and percutaneous coronary intervention. J Am Coll Cardiol 2010;56:254263.
  • 64
    Williams DO, Holubkov R, Yeh W, et al. Percutaneous coronary intervention in the current era compared with 1985–1986: The national heart, lung, and blood institute registries. Circulation 2000;102:2945.
  • 65
    Klein LW, Uretsky BF, Chambers C, et al. Quality assessment and improvement in interventional cardiology. A position statement of the society of cardiovascular angiography and interventions. I. Standards for quality assessment and improvement in interventional cardiology. Cath Cardiovasc Int 2011;77:927935.
  • 66
    Eggers KM, Lind L, Venge P, Lindahl B. Will the universal definition of myocardial infarction criteria result in an overdiagnosis of myocardial infarction? Am J Cardiol 2009;103:588591.
  • 67
    Brandt RR, Filzmaier K, Hanrath P. Circulating cardiac troponin I in acute pericarditis. Am J Cardiol 2001;87:13261328.
  • 68
    Smith SC, Ladenson JH, Mason JW, Jaffe AS. Elevations of cardiac troponin I associated with myocarditis. Experimental and clinical correlates. Circulation 1997;95:163168.
  • 69
    Boden WE, O'Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007;356:15031516.
  • 70
    Bangalore S, Pursnani S, Kumar S, and Bagos PG. Percutaneous coronary intervention versus optimal medical therapy for prevention of spontaneous myocardial infarction in subjects with stable ischemic heart disease. Circulation 2013;127:769781.
  • 71
    Gustavsson CG, Hansen O, Frennby B. Troponin must be measured before and after PCI to diagnose procedure-related myocardial injury. Scand Cardiovasc J 2004;38:7579.
  • 72
    Miller WL, Garratt KN, Burritt MF, et al. Baseline troponin level: Key to understanding the importance of post-PCI troponin elevations. Eur Heart J 2006;27:10611069.
  • 73
    Kini A, Marmur JD, Kini S, et al. Creatine kinase-MB elevation after coronary intervention correlates with diffuse atherosclerosis, and low-to-medium level elevation has a benign clinical course: Implications for early discharge after coronary intervention. J Am Coll Cardiol 1999;34:663671.
  • 74
    Hong MK, Mehran R, Dangas G, et al. Creatine kinase-MB enzyme elevation following successful saphenous vein graft intervention is associated with late mortality. Circulation 1999;100:24002405.
  • 75
    Tardiff BE, Califf RM, Tcheng JE, et al. Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention: IMPACT-II. J Am Coll Cardiol 1999;33:8896.
  • 76
    Dangas G, Mehran R, Feldman D, et al. Postprocedure creatine kinase-MB elevation and baseline left ventricular dysfunction predict one-year mortality after percutaneous coronary intervention. Am J Cardiol 2002;89:586589.
  • 77
    Ellis SG, Chew D, Chan A, et al. Death following creatine kinase-MB elevation after coronary intervention: Identification of an early risk period: Importance of creatine kinase-MB level, completeness of revascularization, ventricular function, and probable benefit of statin therapy. Circulation 2002;106:12051210.
  • 78
    Ioannidis JP, Karvouni E, Katritsis DG. Mortality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous coronary intervention. J Am Coll Cardiol 2003;42:14061411.
  • 79
    Ajani AE, Waksman R, Sharma AK, et al. Usefulness of periprocedural creatinine phosphokinase-MB release to predict adverse outcomes after intracoronary radiation therapy for in-stent restenosis. Am J Cardiol 2004;93:313317.
  • 80
    Jang JS, Hong MK, Park DW, et al. Impact of periprocedural myonecrosis on clinical events after implantation of drug-eluting stents. Int J Cardiol 2008;129:368372.
  • 81
    Andron M, Stables RH, Egred M, et al. Impact of periprocedural creatine kinase-MB isoenzyme release on long-term mortality in contemporary percutaneous coronary intervention. J Invasive Cardiol 2008;20:108112.
  • 82
    Garbarz E, Iung B, Lefevre G, et al. Frequency and prognostic value of cardiac troponin I elevation after coronary stenting. Am J Cardiol 1999;84:515518.
  • 83
    Bertinchant JP, Polge A, Ledermann B, et al. Relation of minor cardiac troponin I elevation to late cardiac events after uncomplicated elective successful percutaneous transluminal coronary angioplasty for angina pectoris. Am J Cardiol 1999;84:5157.
  • 84
    Fuchs S, Kornowski R, Mehran R, et al. Prognostic value of cardiac troponin-I levels following catheter-based coronary interventions. Am J Cardiol 2000;85:10771082.
  • 85
    Cantor WJ, Newby LK, Christenson RH, et al. Prognostic significance of elevated troponin I after percutaneous coronary intervention. J Am Coll Cardiol 2002;39:17381744.
  • 86
    Herrmann J, Von Birgelen C, Haude M, et al. Prognostic implication of cardiac troponin T increase following stent implantation. Heart 2002;87:549553.
  • 87
    Nallamothu BK, Chetcuti S, Mukherjee D, et al. Prognostic implication of troponin I elevation after percutaneous coronary intervention. Am J Cardiol 2003;91:12721274.
  • 88
    Kizer JR, Muttrej MR, Matthai WH, et al. Role of cardiac troponin T in the long-term risk stratification of patients undergoing percutaneous coronary intervention. Eur Heart J 2003;24:13141322.
  • 89
    Natarajan MK, Kreatsoulas C, Velianou JL, et al. Incidence, predictors, and clinical significance of troponin-I elevation without creatine kinase elevation following percutaneous coronary interventions. Am J Cardiol 2004;93:750753.
  • 90
    Kini AS, Lee P, Marmur JD, et al. Correlation of postpercutaneous coronary intervention creatine kinase-MB and troponin I elevation in predicting mid-term mortality. Am J Cardiol 2004;93:1823.
  • 91
    Cavallini C, Savonitto S, Violini R, et al. Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: Results of the CK-MB and PCI study. Euro Heart J 2005;26:14941498.
  • 92
    Nageh T, Sherwood RA, Harris BM, Thomas MR. Prognostic role of cardiac troponin I after percutaneous coronary intervention in stable coronary disease. Heart 2005;91:11811185.
  • 93
    Prasad A, Singh M, Lerman A, et al. Isolated elevation in troponin T after percutaneous coronary intervention is associated with higher long-term mortality. J Am Coll Cardiol 2006;48:17651770.
  • 94
    Nienhuis MB, Ottervanger JP, Bilo HJ, et al. Prognostic value of troponin after elective percutaneous coronary intervention: A meta-analysis. Cath Cardiovasc Interv 2008;71:318324.
  • 95
    Hubacek J, Basran RS, Shrive FM, et al. Prognostic implications of C-reactive protein and troponin following percutaneous coronary intervention. Can J Cardiol 2009;25:e42e47.
  • 96
    De Labriolle A, Lemesle G, Bonello L, et al. Prognostic significance of small troponin I rise after a successful elective percutaneous coronary intervention of a native artery. Am J Cardiol 2009;103:639645.
  • 97
    Feldman DN, Minutello RM, Bergman G, et al. Relation of troponin I levels following nonemergent percutaneous coronary intervention to short- and long-term outcomes. Am J Cardiol 2009;104:12101215.
  • 98
    Cavallini C, Verdecchia P, Savonitto S, et al. Prognostic value of isolated troponin I elevation after percutaneous coronary intervention. Circ Cardiovasc Interv 2010;3:431435.
  • 99
    Feldman DN, Kim L, Rene AG, et al. Prognostic value of cardiac troponin-I or troponin-T elevation following nonemergent percutaneous coronary intervention: A meta-analysis. Cath Cardiovasc Interv 2011;77:10201030.